Skip to content
Screener

Avalo Therapeutics AVTX Operating Lease Liability Payments Due

Operating Lease Liability Payments Due at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$51.27M-2.7%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$2.11M+78.5%

Other financials

Income statement

See full
Revenue$59.0K-69.3%
Gross profit$963.0K+8,855%
Operating income-$31.5M-63.2%
Net income-$36.4M-75.1%
EPS (diluted)-$0.83+56.8%

Balance sheet

See full
Cash & equivalents$85.6M+101%
Total debt$242.0K-64.4%
Total equity$448.7M+329%
Total assets$490.8M+288%

Cash flow

See full
Operating cash flow-$20.0M-75.5%
CapEx-
Free cash flow-$15.0M-444%

Valuation

See full
Market cap$1.06B+987%
Enterprise value$974.89M+1,651%

Profitability

See full
Gross margin182%+176pp
Operating margin-15,536.1%-17,275pp
Net margin-7,965.8%-10,750pp
FCF margin-11,123.8%-13,374pp

Returns & leverage

See full
Return on equity-36.3%
Debt / equity0.0×
Current ratio19.3×+6.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.

The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:03 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001534120-26-000049
Line itemUndiscounted Cash FlowsUndiscounted Cash Flows
July 1, 2026 through December 31, 2026$$189
202763
Total lease payments$$252
Less implied interest(10)
Total$$242

Item 1. Financial Statements.

FAQ

What is Avalo Therapeutics's operating lease liability payments due?
Avalo Therapeutics (AVTX) reported operating lease liability payments due of $252K in Q2 2026.
How has Avalo Therapeutics's operating lease liability payments due changed year-over-year?
Avalo Therapeutics's operating lease liability payments due decreased by 65.7% year-over-year, from $735K to $252K.
What does operating lease liability payments due mean?
This represents the total future cash outflows required to satisfy operating lease agreements. It reflects the company's reliance on leased assets rather than owned assets to conduct business operations. Monitoring this helps evaluate the company's operational leverage and fixed cost structure.

Ask your AI about Avalo Therapeutics's operating lease liability payments due.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude